Plasma C-type natriuretic peptide forms and thyroid status in prepubertal children with acquired thyroid disease

Clinical Endocrinology

Volumn 76, Issue 2, 2012, Pages 228-235

  Reh, C S ^a   Olney, R C ^b   Azen, C ^c   Prickett, T C ^d   Espiner, E A ^d   Geffner, M E ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NEMOURS CHILDREN S CLINIC   (United States)

^c CHILDREN S HOSPITAL LOS ANGELES   (United States)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C; SOMATOMEDIN C; THYROID HORMONE;

ARTICLE; BODY HEIGHT; CHILD; CLINICAL ARTICLE; FEMALE; HEIGHT VELOCITY; HORMONE BLOOD LEVEL; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ALKALINE PHOSPHATASE; BONE DEVELOPMENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; NATRIURETIC PEPTIDE, C-TYPE; PROSPECTIVE STUDIES; PUBERTY; THYROID DISEASES;

EID: 84855455370     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04187.x     Document Type: Article

References (29)

1. Potter, L.R., Abbey-Hosch, S., &, Dickey, D.M., (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews, 27, 47-72. (Pubitemid 43228238)
2. Minamino, N., Aburaya, M., Kojima, M., et al. (1993) Distribution of C-type natriuretic peptide and its messenger RNA in rat central nervous system and peripheral tissue. Biochemical and Biophysical Research Communications, 197, 326-335. (Pubitemid 23358915)
3. Olney, R.C., (2006) C-type natriuretic peptide in growth: a new paradigm. Growth Hormone IGF Research, 16 (Suppl. A), S6-S14.
4. Prickett, T.C., Yandle, T.G., Nicholls, M.G., et al. (2001) Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochemical and Biophysical Research Communications, 286, 513-517. (Pubitemid 32912975)
5. Prickett, T.C., Lynn, A.M., Barrell, G.K., et al. (2005) Amino-terminal proCNP: a putative marker of cartilage activity in postnatal growth. Pediatric Research, 58, 334-340. (Pubitemid 41099883)
6. Prickett, T.C., Dixon, B., Frampton, C., et al. (2008) Plasma amino-terminal pro C-type natriuretic Peptide in the neonate: relation to gestational age and postnatal linear growth. Journal of Clinical Endocrinology and Metabolism, 93, 225-232.
7. Olney, R.C., Prickett, T.C., Yandle, T.G., et al. (2007) Amino-terminal propeptide of C-type natriuretic peptide and linear growth in children: effects of puberty, testosterone, and growth hormone. Journal of Clinical Endocrinology and Metabolism, 92, 4294-4298. (Pubitemid 350074747)
8. Prickett, T.C., Barrell, G.K., Wellby, M., et al. (2007) Response of plasma CNP forms to acute anabolic and catabolic interventions in growing lambs. American Journal of Physiology. Endocrinology and Metabolism, 292, E1395-E1400. (Pubitemid 46684608)
9. Gogakos, A.I., Duncan Bassett, J.H., &, Williams, G.R., (2010) Thyroid and bone. Archives of Biochemistry and Biophysics, 503, 129-136.
10. Prader, A., Largo, R.H., Molinari, L., et al. (1989) Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helvetica Paediatrica Acta. Supplementum, 52, 1-125.
11. Greulich, W.W., &, Pyle, S.I., (1959) Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd edn. Stanford University Press, Stanford, CA.
12. Olney, R.C., Permuy, J.W., Warde, M.K., et al. (2010) Amino-terminal propeptide of c-type natriuretic peptide (NTproCNP): reference range and levels in children with idiopathic short stature treated with growth hormone. Growth Hormone & IGF Research, 20 (Suppl.1), S45 (Abstract P16).
13. Stevens, D.A., Hasserjian, R.P., Robson, H., et al. (2000) Thyroid hormones regulate hypertrophic chondrocyte differentiation and expression of parathyroid hormone-related peptide and its receptor during endochondral bone formation. Journal of Bone and Mineral Research, 15, 2431-2442.
14. Bassett, J.H., Swinhoe, R., Chassande, O., et al. (2006) Thyroid hormone regulates heparan sulfate proteoglycan expression in the growth plate. Endocrinology, 147, 295-305. (Pubitemid 43004283)
15. Sellitti, D.F., Puggina, E., Lagranha, C., et al. (2004) cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells. Journal of Endocrinology, 180, 23-34. (Pubitemid 38180754)
16. Prickett, T.C., Charles, C.J., Yandle, T.G., et al. (2009) Skeletal contributions to plasma CNP forms: evidence from regional sampling in growing lambs. Peptides, 30, 2343-2347.
17. Prickett, T.C.R., Bothwell, J.C., Yandle, T.G., et al. (2010) Pharmacodynamic responses of c-type natriuretic peptide to GH in growth hormone deficient rats: correlation with linear growth. The 92th Annual Meeting of the Endocrine Society, San Diego, CA, (Abstract P3-234).
18. Lassova, L., Niu, Z., Golden, E.B., et al. (2009) Thyroid hormone treatment of cultured chondrocytes mimics in vivo stimulation of collagen X mRNA by increasing BMP 4 expression. Journal of Cellular Physiology, 219, 595-605.
19. Wang, L., Shao, Y.Y., &, Ballock, R.T., (2010) Thyroid hormone-mediated growth and differentiation of growth plate chondrocytes involves IGF-1 modulation of beta-catenin signaling. Journal of Bone and Mineral Research, 25, 1138-1146.
20. Yasoda, A., Komatsu, Y., Chusho, H., et al. (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nature Medicine, 10, 80-86. (Pubitemid 38524702)
21. Ulici, V., Hoenselaar, K.D., Gillespie, J.R., et al. (2008) The PI3K pathway regulates endochondral bone growth through control of hypertrophic chondrocyte differentiation. BMC Developmental Biology, 8, 40.
22. Kawasaki, Y., Kugimiya, F., Chikuda, H., et al. (2008) Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. Journal of Clinical Investigation, 118, 2506-2515. (Pubitemid 351949778)
23. Chusho, H., Tamura, N., Ogawa, Y., et al. (2001) Dwarfism and early death in mice lacking C-type natriuretic peptide. Proceedings of the National Academy of Sciences of the United States of America, 98, 4016-4021. (Pubitemid 32249890)
24. Pantazi, H., &, Papapetrou, P.D., (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. Journal of Clinical Endocrinology and Metabolism, 85, 1099-1106. (Pubitemid 32269356)
25. Siddiqi, A., Burrin, J.M., Noonan, K., et al. (1997) A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density. Journal of Clinical Endocrinology and Metabolism, 82, 753-759. (Pubitemid 27106582)
26. Sabuncu, T., Aksoy, N., Arikan, E., et al. (2001) Early changes in parameters of bone and mineral metabolism during therapy for hyper- and hypothyroidism. Endocrine Research, 27, 203-213. (Pubitemid 32565589)
27. Suda, M., Tanaka, K., Fukushima, M., et al. (1996) C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system. Biochemical and Biophysical Research Communications, 223, 1-6.
28. Purandare, A., Co, N.L., Godil, M., et al. (2003) Effect of hypothyroidism and its treatment on the IGF system in infants and children. Journal of Pediatric Endocrinology & Metabolism: JPEM, 16, 35-42. (Pubitemid 37259090)
29. Ohlsson, C., Mohan, S., Sjogren, K., et al. (2009) The role of liver-derived insulin-like growth factor-I. Endocrine Reviews, 30, 494-535.